Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet and dexamethasone in relapsed/refractory cerebral lymphoma
NCT01848652Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Oct 2013
- Primary completion
- May 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in primary central nervous system lymphoma (PCNSL), sponsored by Centre Hospitalier Universitaire de Brest. Started Oct 2013; status: terminated.
02
Drugs
doxorubicin
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT01848652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848652.